Institute for Quality and Efficiency in Health Care

Dimethyl fumarate for MS: Added benefit is not proven

Dimethyl fumarate (trade name: Tecfidera) has been approved since January 2014 for adults with relapsing remitting multiple sclerosis (RRMS). In an early benefit assessment pursuant to the Act on the Reform of the Market ...

Aug 07, 2014
popularity not rated yet | comments 0

Breast cancer: DMP is largely consistent with guidelines

On 16 July 2014 the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with breast cancer. ...

Jul 16, 2014
popularity not rated yet | comments 0